Arthritis National Research Foundation
Title: An articular cartilage stem cell mediating cartilage regeneration for the treatment of osteoarthritis
Principal Investigator: Seoyeon Bok, PhD
Period of Support: 7/01/2023 – 6/30/2024
Total Direct Costs: $125,000
National Institutes of Health (R01 grant)
Title: Role of the CD44/Hyaluronan axis in mesenchymal prostate cancer
Principal Investigator: Maria Diaz-Meco Conde, PhD
Period of Support: 08/01/2023-07/31/2028
Total Direct Costs: $1,621,735
The American Society for Bone and Mineral Research
Title: A multi-stem cell basis for craniosynostosis
Principal Investigator: Shawon Debnath, PhD
Period of Support: 01/01/2023 – 12/31/2023
Total Direct Costs: $15,000
Manhasset Women’s Coalition Against Breast Cancer
Title: Carbon Monoxide-Based Approach for Metastatic Breast Cancer Prevention and Therapy
Principal Investigator: Yi Chieh (Nancy) Du, PhD
Period of Support: 10/25/2023 – 10/25/2025
Total Direct Costs: $86,956
Mary Kay Foundation
Title: New Approaches to Target Vertebral Metastases in Breast Cancer
Principal Investigator: Matthew Blake Greenblatt, MD, PhD
Period of Support: 7/01/2023 – 6/30/2025
Total Direct Costs: $100,000
Pershing Square Foundation
Title: A Bone to Brain Axis Controlling Alzheimer's Disease Progression
Principal Investigator: Matthew Blake Greenblatt, MD, PhD
Period of Support: 7/01/2023 – 6/30/2026
Total Direct Costs: $750,000
SPROUT award (Cornell University, Ithaca, NY)
Title: Matrix-regulation of tumor dormancy and immunoregulation in breast cancer bone metastasis
Principal Investigator: Matthew Blake Greenblatt, MD, PhD
Period of Support: 7/01/2023 – 6/30/2024
Total Direct Costs: $13,000
William Rhodes and Louise Tilzer-Rhodes Center for Glioblastoma
Title: A novel calvarial stem cell regulating glioblastoma anti-tumor immunity metastasis
Principal Investigator: Matthew Blake Greenblatt, MD, PhD
Period of Support: 7/01/2023 – 6/30/2024
Total Direct Costs: $100,000
Cornell China Center
Title: A stem Cell Basis for Vertebral Metastases
Principal Investigator: Matthew Blake Greenblatt, MD, PhD
Period of Support: 7/01/2023 – 6/30/2024
Total Direct Costs: $15,000
Children’s Tumor Foundation
Title: A skeletal stem cell basis and novel therapeutic approaches for fracture healing defects in Neurofibromatosis type 1
Principal Investigator: Sun Jun, PhD
Period of Support: 7/01/1023 – 6/30/2025
Total Direct Costs: $157,830
United States Department of Defense
Title: Elucidating the oncogenic role of EMSY in non-small cell lung cancer
Principal Investigator: Antonio Marzio, PhD
Period of Support: 01/01/2024-12/31/2026
Total Direct Costs: $374,877
National Institutes of Health (R01 grant)
Title: Elucidating mechanisms of therapy-resistance to interferon-alfa in myeloproliferative neoplasm stem cells
Principal Investigator: Seung Ha Nam, MD
Period of Support: 08/15/2023-05/31/2027
Total Direct Costs: $2,167,872
Alzheimer's Association
Title: The mechanisms driven by microglial FOXO3 underlying AD progression
Principal Investigator: Jihye Paik, PhD
Period of Support: 11/01/2023 – 10/31/2026
Total Direct Costs: $181,818
National Institutes of Health (R01 grant)
Title: DNMT and TET1 reprogramming as a targetable mechanism of resistance in advanced prostate cancer
Principal Investigator: David Rickman, PhD
Period of Support: 06/01/2023-05/31/2028
Total Direct Costs: $2,579,570
National Institutes of Health (R50 grant)
Title: Molecular mechanisms driving therapy-induced lineage plasticity
Principal Investigator: Juan Francisco Linares Rodriguez, PhD
Period of Support: 09/19/2023-08/31/2028
Total Direct Costs: $474,115
American Urological Association
Title: Characterizing the mechanistic co-operation of DNMT and EZH2 in mediating lineage plasticity in advanced prostate cancer
Principal Investigator: Richa Singh, PhD
Period of Support: 11/20/23-11/19/25
Total Direct Costs: $80,000
National Institutes of Health (R01 grant)
Title: Discovering how autophagy is sufficient to extend yeast replicative lifespan
Principal Investigator: Jessica Tyler, PhD
Period of Support: 09/01/2023 – 04/30/2028
Total Direct Costs: $1,583,845
National Institutes of Health (R01 subaward)
Title: Development of Targeted Antipseudomonal bacterial prodrugs
Principal Investigator: Lars Westblade PhD
Period of Support: 02/04/2023-01/31/2028
Total Direct Costs: $199,995
Hospital For Special Surgery T32 (T32AR071302-01) from NIH-NIAMS
Title: HSS Research Institute Rheumatology Training program
Principal Investigator: Alisha Yallowitz, PhD
Period of Support: 2/1/2023 – 1/31/2024
Total Direct Costs: $86,550
Weill Cornell Medicine Internal Grants
2023 Tri-Institutional Breakout Award
Title: Research study on skeletal stem cells
Principal Investigator: Shawon Debnath, PhD
Period of Support: 7/01/2023 – 6/30/2024
Total Direct Costs: $25,000
Primary Parents (RAPP) Award of the Mastercard Diversity-Mentorship Collaborative
Title: Identifying the skeletal adipocyte/osteoblast bipotent cell
Principal Investigator: Alisha Yallowitz, PhD
Period of Support: 7/01/2023 – 6/30/2024
Total Direct Costs: $50,000
SPORE in Prostate Cancer WCM
Title: Investigating the Role of Lipid Metabolism in Overcoming Androgen Resistance in Metastatic Castration-Resistant Prostate Cancer
Principal Investigator: Pier Nuzzo, MD PhD
Period of Support: 11/01/2023-10/31/2024
Total Direct Costs: $75,000
SPORE in Prostate Cancer WCM
Title: A Stem Cell Basis for Prostate Cancer Vertebral Metastases and Osteoblastic Lesions
Principal Investigator: Matthew Blake Greenblatt, MD, PhD
Period of Support: 11/01/23 to 10/31/24
Total Direct Costs: $75,000
Industry Sponsored Research Agreements
Hardy Diagnostics Inc.
Title: NG-Test CTX-M Multi assay
Principal Investigator: Lars Westblade, PhD
Period of Support: 7/10/2023-07/09/2024
Total Direct Costs: $22,310
Bio-Rad Laboratories
Title: Deciphering PCa Bone Metastasis Mechanisms through Targeted CTC Isolation
Principal Investigator: Mohammad Omar, MBBCH
Period of Support: 09/01/2023-08/31/2024
Total Direct Costs: $50,000
Fellowships
American Italian Cancer Foundation
Title: Investigating the role of KEAP1 in the modulation of anti-tumor immunity in non-small cell lung cancer (NSCLC)
Principal Investigator: Alessandra Ferri, PhD
Period of Support: 08/01/2023-07/31/2024
Total Direct Costs: $40,000
American Italian Cancer Foundation
Title: Generation of fully humanized murine avatars of B-ALL patients for the study of refractoriness and relapse in a bedside approach
Principal Investigator: Giovanni Medico MD
Period of Support: 08/01/2023-07/31/2024
Total Direct Costs: $40,000
American Italian Cancer Foundation
Title: Loss of Stromal Androgen Receptor (AR) Signaling Contributes to Progression in Prostate Cancer
Principal Investigator: Filippo Pederzoli, MD PhD
Period of Support: 08/01/2023-07/31/2024
Total Direct Costs: $40,000